SpaceX Hits $2T Cap; Broadcom Raises AI Forecast to $115B
SpaceX reclaimed a $2 trillion market cap after a 7.6% surge on an Oppenheimer upgrade, while Broadcom raised its AI chip revenue forecast to $115 billion
This update is a roundup of same-day reporting from the linked sources below, with editorial context from the CPJ Stock Desk.
SpaceX is back in the $2 trillion club, Broadcom’s AI outlook just got bigger, and Anthropic is quietly lining up $15 billion in credit ahead of a widely-watched IPO. Here is what moved markets on September 3-4.
Key points
- SpaceX (SPCX) surged 7.6% to approximately $151, pushing its market cap back above $2 trillion for the first time in two months.
- Oppenheimer raised its SpaceX price target from $250 to $280, citing AI growth prospects as a key driver alongside the satellite and launch businesses.
- Broadcom now expects AI chip revenue of roughly $115 billion in fiscal 2027, up from prior guidance, with customers including Meta, Google, and OpenAI.
- AVGO shares still fell about 5% on the earnings reaction, illustrating how far investor expectations have run ahead of even strong results.
- Anthropic is nearing a $15 billion revolving credit facility, a meaningful balance-sheet move ahead of its anticipated IPO.
What is actually driving the SpaceX bounce?
The Oppenheimer upgrade is the most visible catalyst, but two other things are worth tracking. First, the September 9 share unlock has been front of mind for traders, and the stock climbing into that event suggests at least some buyers are not waiting on the sidelines. Second, Oppenheimer’s revised thesis leans on AI as a revenue driver for SpaceX, specifically the intersection of satellite broadband and the broader data infrastructure buildout. That framing is relatively new and gives the stock a narrative that goes beyond launch cadence.
At $151 with a $280 target, the implied upside is large on paper. But SpaceX remains a private-market vehicle with limited liquidity and disclosure compared to a typical public company. Investors considering exposure through alternative names such as Rocket Lab, AST SpaceMobile, or Redwire get different risk and liquidity profiles, not a direct proxy.
Why did Broadcom fall on record AI numbers?
Broadcom’s AI chip segment posted a 221% increase in revenue, and the company still saw its stock drop roughly 5%. The updated forecast of $115 billion in AI chip sales by fiscal 2027 is a substantial raise, but the market’s reaction reveals the underlying problem: AVGO had already priced in aggressive growth. When a stock trades at a multiple that assumes everything goes right, even a strong beat with a raised guide can disappoint relative to what was whispered.
The Nikkei felt the ripple. Japanese chip-related stocks weighed on the index on September 3, a reminder that sentiment around a single U.S. bellwether can move semiconductor names globally within hours.
Anthropic’s credit facility and what it signals for the IPO watch
Anthropic finalizing a $15 billion revolving credit facility is a notable pre-IPO maneuver. A revolving credit line of that size gives the company operational flexibility without forcing equity dilution at a moment when private AI valuations are under scrutiny. It also suggests Anthropic’s banking relationships are strong enough to underwrite that commitment, which is useful public-market signaling even before a prospectus is filed.
For investors watching the AI IPO pipeline, Anthropic represents one of the highest-profile potential listings still outstanding. The credit deal does not set a timeline, but it does suggest the company is tidying up its capital structure, which tends to precede a filing by months, not years.
One structural story that is easy to miss
Separately, ASML supplier Zeiss put a figure on something that gets discussed but rarely quantified: China is approximately 15 years behind in developing extreme ultraviolet lithography equipment, according to Zeiss semiconductor division head Frank Rohmund. That gap, if accurate, has lasting implications for the competitive position of ASML and its supplier ecosystem. EUV tools are the chokepoint for leading-edge chip production, and a 15-year lag is not something that policy subsidies alone can close quickly. For long-term holders of ASML or related names, that assessment reinforces the durability of the moat.
Nothing in this article is investment advice. All figures are drawn from the sources cited above.
Sources
- All Eyes Are on SpaceX's Next Share Unlock on Sept. 9. But These 3 Unstoppable Growth Stocks Are Better Buys Hiding in Plain Sight. (finance.yahoo.com)
- SpaceX (SPCX) Jumps 7.6% to $151 on Oppenheimer Upgrade (financefeeds.com)
- SpaceX (SPAC) Target Price Increased by Oppenheimer Amidst AI Growth Prospects (gurufocus.com)
- SpaceX Reaches $2 Trillion Market Cap with Stock Surge (SPCX.US) (gurufocus.com)
- Broadcom raises AI chip sales forecast to $115 billion by 2028 (business-standard.com)
- China 15 years behind in developing top chipmaking tools: ASML supplier (business-standard.com)
- Broadcom Stock Tumbles as AI Growth Soars 221%. The Problem Is Investor Expectations (gurufocus.com)
- Global Market: Japan’s Nikkei struggles for direction as chip stocks weigh, bond yields fall (economictimes.indiatimes.com)
- Weather Next 3 (etvbharat)
- Nvidia to buy AI platform Hugging Face for $12.9 billion (thehindu)
- Anthropic Nears $15 Billion Credit Deal Ahead of IPO (econotimes)
- I Tested NBA 2K27 With DLSS 5 on an RTX 5070 — Here’s What Happened (gizbot)